FREQUENTLY ASKED QUESTIONS
Participation involves completing a survey, providing a saliva sample, and providing authorization for using a small piece of tissue from your prostate biopsy or prostate surgery that your doctor collected as part of your treatment or care.
You can register on our website and we will contact you.
Participation is open to African American (or Black) men who were first diagnosed with prostate cancer in the United States on Jan. 1, 2015 or later.
We expect that at least 10,000 men will participate from across the United States.
There is no cost to you to participate in the study.
Yes, you could receive up to $50 for your time and effort to participate in all parts of the study.
All of the data and information that you will provide for this study will be kept confidential and will only be used for research purposes. Results from this research project may be published in scientific journals however your identity will not be released. RESPOND researchers have years of experience in protecting patient confidentiality in cancer research.
The RESPOND (Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Immunity and Stress) study is supported by the National Cancer Institute and the National Institute on Minority Health and Health Disparities of the National Institutes of Health, under grant number CA214253, awarded to the University of Southern California in Los Angeles. The content of this product is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding for RESPOND is provided by the Prostate Cancer Foundation. NIH is providing 96% of the total funding ($25.5 million) and PCF is providing 4% of the funding ($1 million).
The investigators include cancer researchers from 11 institutions in the United States. Meet the researchers here.
We plan to keep men informed about the results through newsletters as well as on the respondstudy.org website.